Telomeric rather than centromeric activating KIR genes protect from cytomegalovirus infection after kidney transplantation

American Journal of Transplantation

Volumn 11, Issue 6, 2011, Pages 1302-1307

  Stern, M ^a   Hadaya, K ^b   Honger G ^a   Martin, P Y ^b   Steiger, J ^a   Hess, C ^a   Villard, J ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Activating KIR genes; centromere KIR; CMV infection; kidney transplantation; telomere KIR

Indexed keywords

HLA ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL5A; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS5; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DS1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CENTROMERE; CHILD; CONFIDENCE INTERVAL; CYTOMEGALOVIRUS INFECTION; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; GRAFT RECIPIENT; HAPLOTYPE; HAZARD RATIO; HUMAN; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TELOMERE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CENTROMERE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RECEPTORS, KIR; TELOMERE; YOUNG ADULT;

EID: 79958846283     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03516.x     Document Type: Article

References (19)

1. Humar A, Snydman D,. Cytomegalovirus in solid organ transplant recipients. Am J Transplant 2009; 9 (Suppl 4): S78-S86.
2. Eissens DN, Van Der Meer A, Van Cranenbroek B, Preijers FW, Joosten I,. Rapamycin and MPA, but not CsA, impair human NK cell cytotoxicity due to differential effects on NK cell phenotype. Am J Transplant 2010; 10: 1981-1990.
3. Cook M, Briggs D, Craddock C, et al,. Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation. Blood 2006; 107: 1230-1232. (Pubitemid 43156330)
4. Hadaya K, de Rham C, Bandelier C, et al,. Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation. Am J Transplant 2008; 8: 2674-2683.
5. Stern M, Elsasser H, Honger G, Steiger J, Schaub S, Hess C,. The number of activating KIR genes inversely correlates with the rate of CMV infection/reactivation in kidney transplant recipients. Am J Transplant 2008; 8: 1312-1317. (Pubitemid 351763694)
6. Zaia JA, Sun JY, Gallez-Hawkins GM, et al,. The effect of single and combined activating killer immunoglobulin-like receptor genotypes on cytomegalovirus infection and immunity after hematopoietic cell transplantation. Biol Blood Marrow Transplant 2009; 15: 315-325.
7. Guma M, Angulo A, Vilches C, Gomez-Lozano N, Malats N, Lopez-Botet M,. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 2004; 104: 3664-3671. (Pubitemid 39564443)
8. van Stijn A, Rowshani AT, Yong SL, et al,. Human cytomegalovirus infection induces a rapid and sustained change in the expression of NK cell receptors on CD8+ T cells. J Immunol 2008; 180: 4550-4560.
9. Cooley S, Weisdorf DJ, Guethlein LA, et al,. Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. Blood 2010; 116: 2411-2419.
10. Hiby SE, Apps R, Sharkey AM, et al,. Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J Clin Invest. 2010; 120: 4102-4110.
11. Egli A, Binet I, Binggeli S, et al,. Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients. J Transl Med 2008; 6: 29.
12. Uhrberg M, Valiante NM, Shum BP, et al,. Human diversity in killer cell inhibitory receptor genes. Immunity 1997; 7: 753-763. (Pubitemid 28064889)
13. Hsu KC, Chida S, Geraghty DE, Dupont B,. The killer cell immunoglobulin-like receptor (KIR) genomic region: Gene-order, haplotypes and allelic polymorphism. Immunol Rev 2002; 190: (40 -52). (Pubitemid 36071925)
14. Sun JC, Beilke JN, Lanier LL,. Adaptive immune features of natural killer cells. Nature 2009; 457: 557-561.
15. Moesta AK, Graef T, Abi-Rached L, Older Aguilar AM, Guethlein LA, Parham P,. Humans differ from other hominids in lacking an activating NK cell receptor that recognizes the C1 epitope of MHC class I. J Immunol 2010; 185: 4233-4237.
16. Alter G, Rihn S, Walter K, et al,. HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection. J Virol 2009; 83: 6798-6805.
17. Ye M, Morello CS, Spector DH,. Strong CD8 T-cell responses following coimmunization with plasmids expressing the dominant pp89 and subdominant M84 antigens of murine cytomegalovirus correlate with long-term protection against subsequent viral challenge. J Virol 2002; 76: 2100-2112. (Pubitemid 34150677)
18. Sivori S, Falco M, Moretta L, Moretta A,. Extending killer Ig-like receptor function: From HLA class I recognition to sensors of microbial products. Trends Immunol 2010; 31: 289-294.
19. Jacobsen T, Sifontis N,. Drug interactions and toxicities associated with the antiviral management of cytomegalovirus infection. Am J Health Syst Pharm 2010; 67: 1417-1425.